Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05626504

Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms

Conditions: Brain Aneurysm, Intracranial Hemorrhages, Stroke

Sex: All

Ages: 18 Years – N/A

Enrollment: 50

Sponsor: King's College Hospital NHS Trust

Location: United Kingdom

Summary

In this project the investigators study the safety and efficacy of the pipeline embolization device with vantage technology in treatment of unruptured brain aneurysms

Eligibility Criteria

Inclusion Criteria:All patients treated with Pipeline Embolization Device with Vantage Technology (PEDV)MRA and/or DSA (or tomographic angiography) available for follow upExclusion Criteria:Insufficient background data available e.g., to determine size of aneurysm and pipeline devicePEDV used for causes other than aneurysms, e.g., fistulas and dissection.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05626504). StuddyBuddy aggregates publicly available trial information.